Microbiome Sequencing Service Market Report 2026

Microbiome Sequencing Service Market Overview

• Microbiome Sequencing Service market size has reached to $2.43 billion in 2025 • Expected to grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 16.8% • Growth Driver: Rising Incidence Of Gut-Related Diseases Fueling The Growth Of The Market Due To Lifestyle Changes And Pathogen-Driven Gastrointestinal Infections • Market Trend: Advanced Automated Solutions Transform Microbiome Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Microbiome Sequencing Service Market?

A microbiome sequencing service refers to a scientific service that analyzes the genetic material of microbial communities present in a sample, such as the gut, skin, or environmental samples. It is used to identify, quantify, and characterize the microorganisms to understand their composition, diversity, and potential functional roles. The main services of microbiome sequencing service are sample preparation, sequencing and library preparation, and data analysis. Sample preparation involves the processing of collected biological samples to ensure they are of sufficient quality and purity for sequencing procedures. The various technologies utilized include sequencing by litigation (SBL), sequencing by synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others. It finds applications in autoimmune disorder, cancer, gastrointestinal disorders, and others, serving end-users such as pharmaceutical and biotechnology companies, academic research institutes, and others.

What Is The Microbiome Sequencing Service Market Growth Forecast?

The microbiome sequencing service market size is expected to see rapid growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing clinical adoption of microbiome-based diagnostics, rising investments in microbiome therapeutics, expansion of personalized nutrition research, growing use of ai-driven microbial analysis, increasing demand for large-scale population microbiome studies. Major trends in the forecast period include increasing demand for high-throughput microbiome sequencing services, growing use of shotgun and amplicon sequencing, rising integration of advanced bioinformatics pipelines, expansion of clinical microbiome research applications, enhanced focus on functional microbial profiling.

Global Microbiome Sequencing Service Market Segmentation

1) By Service: Sample Preparation, Sequencing And Library Preparation, Data Analysis 2) By Technology: Sequencing By Litigation (SBL), Sequencing By Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Other Technologies 3) By Application: Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Other End-Users Subsegments: 1) By Sample Preparation: Deoxyribonucleic Acid (DNA) Extraction, Ribonucleic Acid (RNA) Extraction, Protein Extraction, Cell Lysis, Library Construction 2) By Sequencing And Library Preparation: Whole Genome Sequencing, Metagenomic Sequencing, Amplicon Sequencing, Shotgun Sequencing, Targeted Sequencing 3) By Data Analysis: Taxonomic Profiling, Functional Profiling, Comparative Analysis, Statistical Analysis, Pathway Analysis

What Is The Driver Of The Microbiome Sequencing Service Market?

The rising incidence of gut-related diseases is expected to propel the growth of the microbiome sequencing service market going forward. Gut-related diseases refer to medical conditions that affect the gastrointestinal (GI) tract, which includes the stomach, intestines, and associated organs such as the liver, pancreas, and gallbladder. The rising incidence of gut-related diseases is due to changes in lifestyle and dietary habits, such as high consumption of processed foods and low fiber intake, which disrupts gut microbiota balance. Microbiome sequencing service supports gut-related disease management by offering detailed insights into gut microbial composition, making it ideal for diagnosing and monitoring gastrointestinal conditions. They enable targeted interventions by identifying microbial imbalances, improving personalized treatment, and improving overall gut health management. For instance, in June 2025, according to the UK Health Security Agency, a UK-based government agency, the laboratory reports for Campylobacter increased by 27.0% from 96.1 to 122.0 per 100,000 population between 2022 and 2024. Therefore, the rising incidence of gut-related diseases is driving the growth of the microbiome sequencing service industry.

Key Players In The Global Microbiome Sequencing Service Market

Major companies operating in the microbiome sequencing service market are Eurofins Scientific LLC, Illumina Inc., Charles River Laboratories, QIAGEN N.V., Mérieux NutriSciences Corporation, OraSure Technologies Inc., Zifo RnD Solutions, Novogene Co. Ltd., Oxford Nanopore Technologies Plc, Macrogen Inc., Zymo Research Corporation, CD Genomics, Molzym GmbH & Co. KG (Gradian Diagnostics), Baseclear BV, Psomagen Inc., Mapmygenome, Rancho Biosciences LLC, Boster Biological Technology Ltd., Clinical Microbiomics, Microba Life Sciences Limited

Global Microbiome Sequencing Service Market Trends and Insights

Major companies operating in the microbiome sequencing service market are focusing on developing advanced solutions, such as automated metagenomics sequencing solutions, to improve efficiency, accuracy, and scalability in microbiome research and analysis. An automated metagenomics sequencing solution is a comprehensive system that enables the sequencing and analysis of microbial communities with minimal manual intervention, ensuring high accuracy, reproducibility, and scalable throughput. For instance, in July 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched the Human Microbiome Metagenomics Sequencing Package. The product offers a fully integrated workflow, combining automated sample pretreatment, nucleic acid extraction, library preparation, sequencing, and data analysis to support high-throughput and cost-efficient microbiome research. Its validated performance on a large number of human stool samples ensures reproducibility and accuracy, establishing a new standard for large-scale human microbiome studies.

What Are Latest Mergers And Acquisitions In The Microbiome Sequencing Service Market?

In May 2025, Mapmygenome India Limited, an India-based genomics and diagnostics company, acquired Microbiome Insights Inc. for an undisclosed amount. With this acquisition, Mapmygenome aims to expand its capabilities in microbiome sequencing and analysis, strengthen its presence in the North American market, and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc. is a Canada-based biotechnology company specializing in microbiome sequencing services.

Regional Outlook

North America was the largest region in the microbiome sequencing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Microbiome Sequencing Service Market?

The microbiome sequencing service market includes revenues earned by entities through microbiome biomarker discovery, host-microbiome interaction analysis, microbial strain identification, metatranscriptomic profiling, metaproteomic analysis, metabolomic profiling, microbiome-based diagnostics development, and microbiome therapeutics support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Microbiome Sequencing Service Market Report 2026?

The microbiome sequencing service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome sequencing service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.